Looking to publish in Advances in Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginAdvances in Therapy is an international, hybrid, peer-reviewed single-blind journal covering therapies, devices, and surgical techniques across all therapy areas. It emphasizes rapid publication, broad inclusion of scientifically sound research including positive, confirmatory, and negative data, and accepts work from clinical phase, real-world, and health economics outcomes studies for both international and country-specific audiences.
Looking to publish in Advances in Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Advances in Therapy accepts the following article types. Click on an article type to view submission instructions.
Original Research
Reviews
Narrative Review
Systemic Review
Brief Reports
Case Series
Guidelines
Letters To The Editor
Recent Publications
Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel as Second-Line Treatment for Large B Cell Lymphoma in the United States
Kristen A. Deger, Fei Fei Liu, Sven L. Klijn, Conrado Franco-Villalobos, Sonja V. Sorensen, Matthew Lunning
Safety and Effectiveness of Dolutegravir/Rilpivirine in Japanese People Living with HIV: Final Report of 6-Year Post-marketing Surveillance Study
Akemi Sebata, Takako Nagao, Tomoko Matsukawa, Yoichiro Yoshikawa, Akiko Fukuda, Dong Wang
Impact of Budesonide/Glycopyrronium/Formoterol Initiation on Healthcare Resource Utilization and Estimated Associated Costs and Greenhouse Gas Emissions Across COPD Care in Spain (ORESTES* Study)
Juan Marco Figueira-Gonçalves, Bernardino Alcázar-Navarrete, Alba Ancochea, Teresa Lastres, Fernando de Andrés-Nogales, Carmen Corregidor-García, Eunice Fitas, Joaquín Sánchez-Covisa
The Impact of Diabetes on Risk of Revision Following Anterior Cruciate Ligament Reconstruction: A Real-World Data Study
Aikaterini Eleftheriadou, Matthew Anson, Zien Fozo, Shehzaad Khan, Khalid Al-Hourani, Uazman Alam
Comparative Effectiveness of Mepolizumab Versus Dupilumab in Medicare Fee-for-Service Beneficiaries with Asthma: A Real-World Cohort Study
Guillaume Germain, Emmeline Burrows, Jacob Klimek, Patrick Gravelle, François Laliberté, Arijita Deb
Frequently asked questions
How long does it take to publish?
The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online, and reports a median of 2 days from submission to first decision.
Reformat to Advances in Therapy using Livewrite PremiumWhat are the publication costs?
Open access APC: £3090.00 GBP / $4990.00 USD / €3990.00 EUR. Subscription publishing: no APC.
Reformat to Advances in Therapy using Livewrite Premium